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OBJECTIVE: To evaluate the effects of a multidisciplinary rehabilitation program on cognition, quality of life, and
neuropsychiatric symptoms in patients with mild Alzheimer’s disease.
METHOD: The present study was a single-blind, controlled study that was conducted at a university-based day-
hospital memory facility. The study included 25 Alzheimer’s patients and their caregivers and involved a 12-week
stimulation and psychoeducational program. The comparison group consisted of 16 Alzheimer’s patients in waiting
lists for future intervention.
INTERVENTION: Group sessions were provided by a multiprofessional team and included memory training,
computer-assisted cognitive stimulation, expressive activities (painting, verbal expression, writing), physiotherapy,
and physical training. Treatment was administered twice a week during 6.5-h gatherings.
MEASUREMENTS: The assessment battery comprised the following tests: Mini-Mental State Examination, Short
Cognitive Test, Quality of Life in Alzheimer’s disease, Neuropsychiatric Inventory, and Geriatric Depression Scale.
Test scores were evaluated at baseline and the end of the study by raters who were blinded to the group
assignments.
RESULTS: Measurements of global cognitive function and performance on attention tasks indicated that patients
in the experimental group remained stable, whereas controls displayed mild but significant worsening. The
intervention was associated with reduced depression symptoms for patients and caregivers and decreased
neuropsychiatric symptoms in Alzheimer’s subjects. The treatment was also beneficial for the patients’ quality of
life.
CONCLUSION: This multimodal rehabilitation program was associated with cognitive stability and significant
improvements in the quality of life for Alzheimer’s patients. We also observed a significant decrease in depressive
symptoms and caregiver burden. These results support the notion that structured nonpharmacological interventions
can yield adjunct and clinically relevant benefits in dementia treatment.
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INTRODUCTION
Given the progressive, irreversible nature of Alzheimer’s
disease (AD) and the limited symptomatic benefits delivered
by pharmacotherapy,
1,2 the provision of nonpharmacological
treatment in addition to standard outpatient care is an asset
of goodclinical practice. The clinical perceptionsupportsthat
nonpharmacological interventions of various kinds may be
helpful in the long-term global management of the disease.
More controlled studies are required, however, to yield
evidence-based information on the effectiveness of cognitive
rehabilitation.
Rehabilitation is a process of active change that allows
disabled people to reach an ideal level of physical,
psychological, and social functioning in the presence of
ongoing or previous disease or impairment.
3,4 Cognitive
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1395rehabilitation refers to the use of techniques to improve
performance for specific mental functions,
5 whereas neu-
ropsychological rehabilitation, in a broader sense, aims to
help patients and their family members deal with the
cognitive, emotional, and social burden of the disease,
thereby ultimately improving the quality of life.
6,7 Several
methods targeting cognition and functionality have been
proposed for patients with AD dementia.
8-11 Most of these
techniques involve multiprofessional teamwork and include
restructuring of the home environment, nutritional advice,
physical activities, psychological counseling, support for
family members and caregivers, and neuropsychological
rehabilitation.
12 Because AD is a progressive neurodegen-
erative disorder, cognitive stimulation rather than rehabili-
tation per se may be a more appropriate term to refer to the
possible interventions within the context of this disease.
13
The comparison among distinct studies using cognitive
stimulation techniques is sometimes difficult because of a
wide variability in the type, complexity, and duration of
interventions; lack of uniformity in target cognitive func-
tions and training protocols; small sample sizes in the
majority of studies; unavailability of comparison groups;
and other methodological constraints. As a whole, however,
physicians generally accept that cognitive stimulation can
improve cognition and behavioral symptoms of patients
with dementia.
1 Loewenstein et al.
14 showed that a
combination of cognitive and functional rehabilitation with
pharmacological treatment with cholinesterase inhibitors
promoted cognitive and functional stability for patients
with mild AD. Similarly, Talassi et al.
15 recently found that
systematic cognitive training may optimize the benefits of
pharmacological treatment in patients with early-stage AD.
Interestingly, no training-related improvement in memory
was obtained from a 12-week multimodular cognitive
rehabilitation program in older adults.
16 Spector and
colleagues
17 published a multicenter, randomized, placebo-
controlled study on psychosocial interventions in AD
showing that patients who received a 14-session reality
orientation and cognitive stimulation schedule had signifi-
cant benefits in cognition and quality of life. In another
study, Raggi et al.
10 administered a multidisciplinary
rehabilitation program to AD patients in a hospital setting
that used reality orientation and computerized cognitive
training to stimulate attention, language, numerical and
spatial skills, psychomotor speed, and memory. The inter-
vention yielded significant improvements in activities of
daily living, neuropsychiatric symptoms, and cognition.
The objective of the present study was to evaluate the
effect of a multifunctional stimulation program on cogni-
tion, neuropsychiatric symptoms, and quality of life in
patients with mild AD in a controlled, single-blind design.
We also addressed the benefits of this intervention for the
mental health parameters of caregivers.
METHODS
Participants and setting
Forty-one AD patients, who were diagnosed according to
the National Institute of Neurological and Communicative
Disorders and Stroke and the Alzheimer’s Disease and
Related Disorders Association (NINCDS-ADRDA)
18 criteria,
and their respective caregivers were recruited at the memory
clinic of the Psychogeriatric Unit of the Institute of Psychiatry
between August 2007 and June 2009. The study was
approved by the local ethics committee, and informed
consent was obtained from patients and/or caregivers.
Participants were referred from outpatient units dedicated
to psychogeriatric care at the same institution. In addition,
some patients were referred from other sources in the local
community. Inclusion criteria were mild dementia, which
was indicated by a score of 0.5 or 1.0 in the Clinical Dementia
Rating Scale (CDR)
19 and a score of 16 or more in the Mini-
mental State Examination (MMSE),
20 and concomitant
standard pharmacological treatment for AD (i.e., use of
cholinesterase inhibitors and/or memantine in stable ther-
apeutic doses for at least three months).
Measurements
All patients and controls were submitted to clinical,
cognitive, and quality of life assessments by two indepen-
dent raters who were blinded to the group assignments. The
same instruments were used at the baseline and the
endpoint. The assessment battery included the MMSE,
20
which is a brief cognitive screening test that evaluates
temporal and spatial orientation, memory, attention, calcu-
lation, language, and visuoconstructive capacity; the Short
Cognitive Test (SKT),
21 which is a broad cognitive screening
battery that addresses attention, processing speed, and
memory; the Neuropsychiatric Inventory (NPI),
22 which
evaluates the presence of 10 psychiatric symptoms (i.e.,
delusions, hallucinations, irritability, disinhibition, agita-
tion, anxiety, depression, euphoria, apathy, and psychomo-
tor abnormalities); the Geriatric Depression Scale (GDS),
23
and the Quality of Life in Alzheimer’s Disease Evaluation
Scale (QoL-AD).
24 The caregivers were assessed with the
GDS and the caregiver’s protocol of the QoL-AD, which
assessed the caregivers’ perceptions of their patient’s
quality of life.
Although the rehabilitation program included physical
training, and physiotherapy (as detailed below), the assess-
ment protocol did not include direct measures of these
intervention components because the primary goal of the
study was to investigate the effects of multiprofessional
intervention on cognitive, functional, psychiatric, and
quality of life outcome variables. The lack of direct
measures, however, can be regarded as a limitation of the
study.
Intervention
Four distinct intervention groups were formed (one per
semester), and each group contained a maximum of 12
patients plus their respective caregivers. The first 12 patients
to be referred to the service were assigned to the experi-
mental group, and the following 12 patients were assigned
to the waiting-list control group. In the second wave of
intervention, subjects in the first control group were
assigned to the second experimental group, and the next
referrals constituted the second control group. This proce-
dure was repeated for the subsequent waves of intervention.
This recruitment strategy was chosen to avoid delays in
treatment to patients formerly allocated in the control group
(i.e., intervention was provided within a maximum time-lag
of 6 months from referral).
The final sample consisted of 25 patients in the experi-
mental group and 16 patients in the control group. Five
patients with moderate dementia (CDR=2) were referred to
our service during the recruitment phase. Although these
patients did not meet inclusion criteria (their data were not
Cognitive rehabilitation in mild AD
Viola LF et al.
CLINICS 2011;66(8):1395-1400
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sessions was granted for ethical reasons. From the total
sample of 41 patients, five subjects failed to reach the
experimental endpoint: one died, two were unable to
comply with all sessions because of limited accessibility,
and two dropped out for personal reasons. Compliant
patients were able to attend at least 90% of the treatment
sessions (i.e., 22 from a total of 24 treatment days).
Caregivers were mostly represented by family members
(90.2%) of AD patients. Professional caregivers were
expected to spend at least 12 h a day with their patients.
The intervention was administered in group sessions
offered twice a week at the day-hospital facilities for 12
consecutive weeks. Sessions lasted from 9:00 AM to 3:30 PM
(lunch and refreshments were provided and lasted 90
minutes), and the 24 sessions resulted in a total of 120 h of
intervention (5 h daily). The program consisted of the
following activities: cognitive rehabilitation, computer-
assisted cognitive training, speech therapy, occupational
therapy, art therapy, physical training, physiotherapy, and
cognitive stimulation with reading and logic games. Each
activity lasted for 60-90 minutes and was offered once a
week (Table 1). Psychoeducation and psychological coun-
seling were provided in group sessions for caregivers twice
a week. The purpose of these meetings was to explain the
clinical aspects of the disease by focusing on its progressive
course and the expected loss of autonomy of the patient. The
exchange of personal accounts and experiences among
participants was also encouraged. Patients on the waiting
list for forthcoming intervention groups (control group)
received standard outpatient care, including monthly
follow-up visits to the memory clinic.
The rehabilitation sessions contained a variety of compo-
nents. Cognitive rehabilitation was delivered through
exercises to improve attention, memory, spatial and
temporal orientation, and self-adaptations to cognitive
impairment. Computer-assisted cognitive training consisted
of a preparatory session (in which participants were made
familiar with the use of the computer) followed by the
engagement in different tasks that primarily consisted of
memory and attention games (user-friendly and adjustable
for complexity). Art therapy aimed at stimulating cognitive,
emotional, and interpersonal skills through expressive and
artistic techniques, and a special emphasis was placed on
nonverbal expression that was devoid of any critical
judgment of the actual quality of the artistic work.
Occupational therapy was intended to develop resources
and strategies to improve the completion of functional
goals, including training in basic (hygiene, feeding, getting
dressed) and instrumental activities of daily living (paying
bills, shopping, leisure, and social activities). In addition,
patients and caregivers were instructed about the need of
household adaptations to enhance orientation and auton-
omy. Physiotherapy was aimed at improving balance and
preventing falls through exercises administered to patients.
In addition, caregivers were also coached to reinforce
exercises and habits at home. Physical training was offered
as a complementary program for physically able patients to
improve physical conditioning. Special emphasis was
placed on motor, emotional, social, and cognitive aspects.
In addition to strength and balance exercises, patients were
invited to group walks and stretching sessions. Speech
therapy was also provided to enhance general communica-
tion and communication strategies in specific daily-life
situations. The sessions also involved cognitive stimulation
through logic games (e.g., simplified chess and related
games), which consisted of preliminary lessons on the rules
and objectives of the games and was designed to improve
concentration, logical-mathematical reasoning, rapid think-
ing, and decision making.
Statistical analysis
The Kolmogorov-Smirnov test was used to determine
whether study variables followed a normal distribution,
which supported the use of parametric tests (t test for two
independent samples) in the analysis of outcomes. Chi-
square (when necessary, adjusted by the Monte Carlo
method) and independent-sample t tests were used to
assess the similarity between experimental and control
groups at baseline. Paired-sample t tests were used to
address changes from the baseline within each group.
RESULTS
No significant differences were observed in the mean age
and education level between patients in the experimental
and control groups. The average age of the patients was 75
years, and the patients had an average of 10 years of
schooling. In addition, there were slightly more females in
each group (experimental group, 64%; control group, 62%,
p=0.9). All patients were either married or widowed, and
more patients in the experimental group group were
married (56%, N.S.). At baseline, no significant differences
between experimental and control groups were found with
respect to mean scores in the various psychometric tests
pertaining to the assessment battery. Nine patients in the
experimental group and 7 in the control group had
CDR=0.5, whereas 16 patients in the experimental group
and 9 in the control group had CDR=1. Fisher’s exact test
did not indicate any significant difference between the CDR
scores of experimental and control groups.
Most caregivers were family members (34.1% spouses,
56.1% children, 9.8% formal caregivers). The mean age of
the caregivers was 51.6 years (15.3 SD), and the mean
educational level was 9.1 years (4.1 SD). There were no
significant differences for age and education between
caregivers in the experimental and control groups
(p=0.996 and p=0.423, respectively).
Table 1 - Schedule of activities (experimental group).
Time Tuesdays Time Thursdays
9:00-10:30 AM Cognitive rehabilitation (computer-assisted) 9:00-10:30 AM Cognitive rehabilitation
10:30-12:00 AM Art therapy 10:30-12:00 AM Physical training
12:00-1:00 PM Lunch 12:00-1:00 PM Lunch
1:00-2:00 PM Occupational therapy 1:00-2:00 PM Logic games
2:00-2:30 PM Rest 2:00-2:30 PM Rest
2:30-3:30 PM Physiotherapy 2:30-3:30 PM Speech therapy
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for psychometric test scores at baseline and at the end of the
study. Paired-sample t tests addressing within-group
differences (baseline vs. endpoint) in test scores showed
that patients in the control group had a tendency for
cognitive decline, which was indicated by a slight, but
significant, increase in total SKT scores and in the attention
SKT subscore (i.e., higher scores in the SKT mean worse
performance). Conversely, patients in the experimental
group remained stable with respect to the aforementioned
variables. Although the MMSE scores remained unchanged
in both groups (irrespective of treatment), the intervention
was associated with a significant reduction in GDS scores,
which indicated improvement in depressive symptoms
from both the patients’ and caregivers’ perspectives. In
addition, there was a significant decrease in caregiver
distress, which was indicated by a reduction in the NPI
distress subscore. Interestingly, patients and caregivers in
the experimental group also reported an improvement in
their quality of life according to the QoL-AD.
DISCUSSION
This was a single-blind, controlled study addressing the
effects of a nonpharmacological treatment program in AD
patients with mild dementia. The intervention consisted of
an extensive, multimodal stimulation program that pri-
marily focused on the rehabilitation of cognitive abilities;
however, the ultimate goal was to promote well being and
improve quality of life. In regards to cognition, patients in
the experimental group remained stable, whereas those in
the comparison group had a mild but significant worsening
in attention and global performance. We understand that
this effect is plausible given the progressive nature of the
disease, which can render untreated patients prone to
cognitive deterioration over time. Although some cognitive
changes may not have been detected by the MMSE in the
relatively short duration of this study (i.e., three months),
cognitive changes were seen in the SKT. Indeed, there were
significant changes in the total score and the attention
subscore, which indicated subtle worsening of patients
in the control group. Studies involving combined phar-
macological and nonpharmacological treatment with multi-
modal stimulation programs reported slight improvements
in MMSE scores.
8,10 Most studies that have evaluated the
effect of nonpharmacological interventions in AD observed
stabilization or, at most, modest improvement of cognitive
functions.
1 Conversely, untreated patients may show cogni-
tive decline. Our results are in agreement with the findings of
previous studies, which have suggested that robust changes
in cognition are unlikely to occur as a consequence of
cognitive training in patients with AD. Gains tend to be
modest and may be best documented as a slight improve-
ment in certain cognitive domains.
16,25 Compared with the
MMSE, the SKT may be more sensitive to subtle changes
because it is a more comprehensive cognitive assessment
battery andtakesinto account processingspeedandresponse
accuracy.
21,26 In addition, the availability of five parallel
versions of the test makes it less prone to learning effects
upon retesting, which is an important issue in longitudinal
studies.
27
Although well-established outcome measures have
become available in pharmaceutical trials in recent years,
the effects of nonpharmacological interventions may not
be properly identified by commonly used psychometric
tests. Interestingly, functional or quality-of-life outcome
measures may be better tools to measure nonpharmacolo-
gical effects. Thus, negative data based on quantitative
testing must be interpreted with caution, particularly in
light of the clinical experience, which suggests that
qualitative benefits to global function are observed in the
close, continuous management of AD patients. Benefits
associated to nonpharmacological interventions may enco-
mpass minor, nonsignificant changes in test scores, and we
understand that the modification of noncognitive func-
tions may partially explain the clinical perception of
change. In a recent study conducted by our group,
Machado et al.
28 suggested that the impressions of changes
in the quality of life in patients with AD can be better
depicted by a qualitative analysis of patients’ reports than
by objective test scores.
Accordingly, a relevant outcome of the present study was
the reduction of depressive symptoms in patients who
received the intervention along with their caregivers. This
finding is clinically relevant and is in line with similar
studies in the literature
1,10,29 (i.e., there is a high rate of
depression in caregivers of AD patients).
30-32 In addition,
the incidence of neuropsychiatric symptoms was low in
both groups (there was no significant difference between the
groups), which seemed to be because our sample only
contained patients with mild dementia (i.e., those who were
less likely to present with important behavioral manifesta-
tions). Interestingly, participation in the program resulted in
a mild reduction in caregiver distress. In a recent study that
Table 2 - Psychometric test scores at baseline and after
intervention (endpoint).
Variable Group Baseline
# Endpoint p-value*
Mini-Mental State Examination CG 23.3 (3.9) 22.4 (2.8) 0.1
EG 22.6 (2.9) 22.5 (3.8) 0.9
Short Cognitive Test (SKT)
Total SKT score CG 12.6 (5.4) 13.8 (5.5) 0.05
EG 14.5 (5.4) 14.6 (6.1) 0.9
Memory subscore CG 5.5 (1.9) 5.2 (2.2) 0.4
EG 5.2 (2.2) 4.9 (2.6) 0.5
Attention subscore CG 7.1 (5.0) 8.6 (4.8) 0.01
EG 9.3 (4.3) 9.6 (4.7) 0.5
Neuropsychiatric Inventory
Total score CG 36.5 (23.9) 28.7 (18.5) 0.1
EG 27.5 (22.4) 25.9 (20.8) 0.4
Distress subscore CG 13.5 ( 9.1) 13.6 (9.2) 0.9
EG 11.7 (8.9) 9.9 (7.9) 0.02
Geriatric Depression Scale (GDS)
Patient CG 4.3 (3.2) 4.7 (3.4) 0.7
EG 4.7 (3.1) 3.4 (3.0) 0.001
Caregiver CG 4.0 (3.2) 3.9 (3.3) 0.9
EG 3.9 (3.5) 3.1 (2.9) 0.02
Quality of Life in AD Scale
Patient CG 36.1 (5.8) 35.4 (6.1) 0.5
EG 35.2 (5.0) 37.3 (4.4) 0.004
Caregiver CG 31.1 (7.4) 32.7 (6.6) 0.3
EG 30.8 (5.2) 33.0 (6.0) 0.04
EG, experimental group; CG, control group. Values represent means and
standard deviations (SD) of test scores;
*p-values in the right column: paired-sample t tests addressing within-
group differences (baseline vs. endpoint) in test scores (significant
differences are shown in bold).
#Independent-sample t tests comparing mean scores at baseline yielded
nonsignificant differences between EG and CG.
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1398was also conducted in Brazil, Camara et al.
33 reported
decreases in caregiver distress as an indirect benefit of the
rehabilitation of patients with AD. Caring for patients with
dementia is highly stressful because of the progressive loss
of autonomy and the presence of behavioral symptoms
associated with AD. Thus, psychoeducation and psycholo-
gical counseling, which was offered biweekly in the present
study, may have contributed to the reported benefits, even
in the absence of significant changes in the presentation of
the disease.
34,35 Moreover, we found significant improve-
ments in the quality of life for both patients and caregivers
after the intervention. This outcome corroborated earlier
studies
10,28,29,36 suggesting that improvements in quality of
life can be demonstrated by objective measures (to a certain
extent).
The relatively small sample of patients, especially in the
control group, was a limitation of the present study. In
addition, the current intervention program required a
significant investment of time and human resources to
deliver the therapeutic sessions that may not be available in
most settings because of the requirement for specialized
training. Future studies should investigate the contribution
of individual rehabilitation components to the outcome
measures because the present investigation only assessed
the impact of the global rehabilitation protocol. In addition,
there may have been some training redundancies in the
format of the present study (e.g., in the computer assisted
training and cognitive rehabilitation components and in the
physical training and physiotherapy components). In
future protocols, these rehabilitation modalities might be
merged to guarantee the best use of financial and human
resources.
CONCLUSION
The current multimodal stimulation program was bene-
ficial for patients with mild AD. Future studies that are
based on larger, more homogeneous samples and use more
rigorous randomization methods should be pursued in this
field of research.
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